Eubiotics Market

Global Eubiotics Market Size (2024 to 2032)

The global Eubiotics market was valued at USD 5.82 billion in 2023 and is anticipated to reach USD 6.29 billion in 2024 from USD 11.75 billion by 2032, growing at a CAGR of 8.12% from 2024 to 2032.

CURRENT SCENARIO OF THE GLOBAL EUBIOTICS MARKET

The eubiotics market is showcasing evident potential in the mentioned forecasting period.  Eubiotics play a vital role in providing medicinal benefits to livestock, such as preclusion and preventing other diseases common in animals. Apart from this, they also carry nutritional value with them. The increase in the capability of producing eubiotics and commercialization of farming has led agriculture-based industries to take interest in the market lately. Eubiotics are generally used as feed additives for animals. They help prevent various diseases in animals, thus keeping them healthy and, in turn, increasing their productivity. It creates an appropriate balance of the microflora in our gastrointestinal tract and helps in maintaining a hygienic living.

The ban on antibiotics has created an open window for eubiotics to enter the agriculture industry and take their place. It has been one of the major reasons for the recent growth of the eubiotics market. Other important factors driving the global eubiotics market growth include the industrialization of the livestock industry, rising demand for naturally derived products, and increasing instances of livestock disease.

These factors have been responsible for the growth of the market lately, although some of the factors have resulted in being hurdles to the eubiotics market as well. Some of them are competition for raw materials from other industries, regulatory framework, and low awareness of product efficiency.

MARKET DRIVERS

The growth of the eubiotics market is driven by the rising focus on animal welfare. The rising awareness of the artificial feed additives among the general public via digital media is influencing the demand for natural alternatives. In the last few years, there has been a growing recognition of natural products as important alternatives to antibiotics, particularly in promoting growth. Also, animal production is under social pressure to boost efficiency, disease economic setbacks, and ensure product goods safety for consumers. In the coming years, natural feed additives have the potential to become the integral to feeding livestock practices and may be deemed essential for sustainable manufacturing methods, ultimately benefiting the market.

 Apart from this, the market growth is also fuelled by the potential negative effects of the elimination of antibiotics as development boosters on growth performance and gut health, have led to greater interest in identifying alternatives. These options aim to mitigate bacterial infections, enhance the quality of food products, and improve the performance of animals by fostering gut health.

The reduction in the immunity of animals worldwide is another factor propelling the market growth. This can be due to climate change, urbanization, nutrition, etc. The rapid pace of urban development impacts the immunity of livestock in several ways, including environmental pollution, immunosuppression, and pathogen-driven immunostimulation. Also, nutritional deficiencies along with climate change have increased the prevalence of diseases and health conditions in animals.

Additionally, the regulatory landscape around the world is influencing the use of eubiotics. The measures that played a crucial role in shaping this market. Banning the application of applications is one of the most significant steps taken towards animal welfare by North American and European countries, which as a consequence accelerated the growth rate of this market.

MARKET RESTRAINTS

Despite forming favourable policies and guidelines, the regulatory hurdles continue to be the primary restraint for the growth of the eubiotics market. This industry is subject to strict laws and rules regarding product approvals and safety standards. Sailing through the legal or governance practices can be complicated and time-consuming. Hence, it delays the introduction of new solutions to the market and increases functional expenses for companies.

Another factor derailing the expansion of this market is the creation of microbial resistance to antibiotics presents significant health problems within the food chain, impacting both humans and animals. Commercial poultry operations are encountering critical issues that affect their overall performance and gut health. Presently, as a result of these concerns, the application of these antimicrobial growth enhancers in animal feed has been prohibited or outlawed by the European Union, the United States, China, and the South Korea. So, there is an urgent need to identify and develop natural and environmentally sustainable alternatives that can support complete health and enhance growth performance in poultry production, which has become a key area of research.

MARKET OPPORTUNITIES

Microbial muramidase (MR) and Precision glycan are expected to provide potential opportunities for the expansion of the Eubiotics market. MR is glycosyl hydrolytic enzymes made by microorganisms, animals and plants with a high particularity to hydrolyze peptidoglycans the key structural elements of the bacterial cell wall. In broiler research, the addition of MR was shown to improve the digestibility of ileal amino acids derived from crude protein and enhance energy utilization. This can used to boost the gut health of animals and gives positive indications for the market growth. Apart from this, another factor presenting prospects for market growth is PG. It gives a promising solution to the problems faced by the poultry industry in ensuring animal health and meeting the demand for lower antibiotic application. As they are chemically synthesized, precision glycans possess a defined profile of glycan chains, including a specific degree of polymerization and glycosidic bonds, enabling complete processing by the microbiota and fostering a shift towards a healthier one and particular microbiome pathways.

MARKET CHALLENGES

The disruption of the vitamin market is affecting the growth of the eubiotics market. With the fourth quarter of 2024 coming to an end, the vitamin industry worldwide is going through a hard time. Rising costs, production halts, and disruption in the supply chain are causing major uncertainty and volatility. The disturbances in this sphere is affecting the market.

• For instance, on 29 July 2024, in Germany, a fire broke out at a prominent vitamin producer’s plant, severely impacting the manufacturing of carotenoids, and vitamins E and A. The manufacturer has since declared Force Majeure and estimates that operations will not restart before January 2025.

Thin instability and ambiguity have resulted in growing agitation or anxiety in the market in the past weeks because vitamins continue to be important in animal nutrition with any curtailment in dependence on unverified substitutes or inclusion levels having the ability to heavily affect the profitability of business. Industry players must prioritise agility, closely track market changes, and secure their supply chains to effectively manage its difficult phase.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global Eubiotics Market By Type

Probiotics are the leading segment of the eubiotics market and are expected to maintain their position during the forecast period. The rise in the segment’s market share can be attributed to the increased awareness of gut health, consumer preferences for natural products, efficacy in enhancing animal performance, etc. The growing knowledge of its applications in feeding livestock, more support for R&D projects to determine or identify innovative solutions, and a wider portfolio of leading market players are taking the segment forward.

Probiotics are further fragmented in lactobacilli, bifidobacteria, and others. Prebiotics are segmented into inulin, fructooligosaccharides, galactooligosaccharides, and others. Probiotics lead the market share under type segmentation because of their efficiency over other types.

Global Eubiotics Market By Livestock

Poultry is the biggest user in the eubiotics market. This segment is expected to have the highest CAGR among all the sub-segments of livestock, as Eubiotics help increase the growth rate of poultry and maintain their high nutritional value. Moreover, the extensive consumption also drives the expansion of the segment’s market size. Poultry meat and egg production play a vital role in feeding the global population while staying within ecological limits. Both chicken and eggs are highly important for humans, they form the base of the market growth. Together, they represent a widely consumed protein source for billions of people.

REGIONAL ANALYSIS

Eubiotics market was dominated by Europe. It was followed by Asia-Pacific and North America. The European market is propelled by regulatory changes and a strict stance on the animal health. Moreover, the regional market grew further with the funding of WOAH’s ZOOSURSY project by the European Union. However, the market in this region is also facing challenges. For instance, the vitamin D3 market is facing tighter conditions due to global supply chain disruptions and EU import restrictions, leading to escalating prices and growing uncertainty. In North America, where supplies are especially limited, prices have been rising significantly. As we come to near the end of the 4^th quarter, the situation continues to be unpredictable, with availability still uncertain.

The Asia Pacific is predicted to grow at a rapid pace in the coming few years with the help of investments from several multinational manufacturers. Economies like China, India , and other developing countries are expected to propel the regional market growth.

KEY PLAYERS IN THE GLOBAL EUBIOTICS MARKET

Some of the major companies dominating the eubiotics market through their products and services include Addcon, Royal DSM, BASF SE, and CHR. Hansen A/S, Kemin Industries Inc., Cargill Incorporated, E. I. Du Pont De Nemours and Company, Novus International Inc., Behn Meyer Group and Beneo Group.

RECENT HAPPENINGS IN THE GLOBAL EUBIOTICS MARKET 

• In November 2024, Format Solutions and dsm-firmenich’s Animal Nutrition & Health division jointly announced the signing of a strategic partnership intended to manage and quantify the ecological effects of animal feed. Format Solutions is a prominent company dealing in integrated formulation and feed ERP software. Moreover, this alliance combines formulation software by Format Solutions with Sustel, a comprehensive life cycle assessment (LCA) platform, which is expected to improve its position and reach in this market. This incorporation enables consumers to determine or estimate and effortlessly share their food footprints.
• In October 2024, the World Organisation for Animal Health (WOAH) introduces ZOOSURSY. It is a new disease surveillance project financed by the European Union. It began in the same month of this year and leverages the success of the EBO-SURSY project by WOAH. In addition, after 7 years of enhancing the surveillance abilities of nations for zoonotic diseases, this project was shut down in July 2024. So, ZOOSRSY is the sequel project.

DETAILED SEGMENTATION OF THE GLOBAL EUBIOTICS MARKET INCLUDED IN THIS REPORT

This research report on the global eubiotics market has been segmented and sub-segmented into the following categories.

By Type

• Probiotics
• Prebiotics
• Organic Acids
• Essential Oils

By Livestock

• Ruminant
• Poultry
• Swine
• Aquaculture
• Horses
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa